Kidney Cancer Coverage from Every Angle
Advertisement
Advertisement

Toni K. Choueiri, MD, on the Impact of COVID-19 on Patients With Kidney Cancer

Posted: Monday, February 8, 2021

Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses his work with the COVID-19 and Cancer Consortium to learn more about the factors that increase the risk of death in patients with renal cell cancer, including barriers to the adoption of telehealth.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.